Concert Pharmaceuticals
CNCE
#7570
Rank
NZ$0.67 B
Marketcap
NZ$14.00
Share price
0.00%
Change (1 day)
72.04%
Change (1 year)

Concert Pharmaceuticals (CNCE) - Total debt

Total debt on the balance sheet as of September 2022 : NZ$23.77 Million

According to Concert Pharmaceuticals 's latest financial reports the company's total debt is NZ$23.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Concert Pharmaceuticals - Total debt on balance sheet (from 2012 to 2022)

Total debt by year

Year Total debt Change
2021-12-31NZ$22.05 M-0.51%
2020-12-31NZ$22.16 M-8.2%
2019-12-31NZ$24.14 M
2015-12-31N/A-100%
2014-12-31NZ$9.06 M-51.95%
2013-12-31NZ$18.86 M-24.84%
2012-12-31NZ$25.09 M133.72%
2011-12-31NZ$10.73 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AbbVie
ABBV
NZ$114.97 B 483,562.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ$62.82 M 164.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$9.07 B 38,094.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Ardelyx
ARDX
NZ$0.34 B 1,360.71%๐Ÿ‡บ๐Ÿ‡ธ USA